Literature DB >> 24594901

Self-irradiation of the blood from selected nuclides in nuclear medicine.

H Hänscheid1, M Fernández, U Eberlein, M Lassmann.   

Abstract

Nuclear medicine dosimetry and research in biodosimetry often require the knowledge of the absorbed dose to the blood. This study provides coefficients for the absorbed dose rates to the blood related to the activity concentration in the blood as a function of the vessel radius for radionuclides commonly used in targeted radiotherapy and in PET-diagnostics: C-11, F-18, Ga-68, Y-90, Tc-99 m, I-124, I-131, and Lu-177. The energy deposition patterns after nuclear disintegrations in blood vessel lumina (cylinders homogeneously filled with blood) with radii from 0.01 to 25.0 mm were simulated with the Monte-Carlo radiation transport code MCNPX. An additional contribution from photon radiation from activity in blood in the remainder of the body was taken into account based on a reasonable blood distribution model. The fraction of energy absorbed from non-penetrating radiation in the blood is low in thin blood vessels but approaches the total energy emitted by particles with increasing lumen radius. For photon radiation, irradiation to blood in small vessels is almost completely due to radioactive decays in distant blood distributed throughout the body, whereas the contribution from activity in the vessel becomes dominant for lumen radii exceeding 13 mm. The dependences of the absorbed dose rates on the lumen radius can be described with good accuracy by empirical functions which can be used to determine the absorbed doses to the blood and to the surrounding tissue.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24594901     DOI: 10.1088/0031-9155/59/6/1515

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  4 in total

1.  Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted Radionuclide.

Authors:  David A Edmondson; Erin E Karski; Ayano Kohlgruber; Harsha Koneru; Katherine K Matthay; Shelly Allen; Christine L Hartmann; Leif E Peterson; Steven G DuBois; Matthew A Coleman
Journal:  Radiat Res       Date:  2016-08-24       Impact factor: 2.841

2.  DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy.

Authors:  Uta Eberlein; Carina Nowak; Christina Bluemel; Andreas Konrad Buck; Rudolf Alexander Werner; Harry Scherthan; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-06       Impact factor: 9.236

3.  Calibration of the γ-H2AX DNA double strand break focus assay for internal radiation exposure of blood lymphocytes.

Authors:  Uta Eberlein; Michel Peper; Maria Fernández; Michael Lassmann; Harry Scherthan
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

4.  DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with 131I.

Authors:  S Schumann; H Scherthan; K Pfestroff; S Schoof; A Pfestroff; P Hartrampf; N Hasenauer; A K Buck; M Luster; M Port; M Lassmann; U Eberlein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-11-13       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.